Fantastic meeting on Cell Therapy in Paris, May 2024! Justin Eyquem Belkaid Lab @realFlorentGinhoux Katy Rezvani, M.D., Ph.D @MarsonLab Majzner_Lab Julie Helft Alena Gros @amigorena Roychoudhuri Lab Luca Gattinoni Claire Roddie Suman MITRA Laurie Menger @CecileAlanio @MichelSadelain

🎅Le #PèreNoël a eu un #cancer... et en a guéri grâce aux équipes de Gustave Roussy. 👀Découvrez cette « histoire vraie. » 📽️Conçu par Publicis Conseil, réalisé par Vladimir de Fontenay et produit par Iconoclast.tv, le film est un #ConteDeNoëlModerne ⤵️ vu.fr/ZnJkK

@realFlorentGinhoux Very excited to share SOPA! This has been a wonderful collaboration with Quentin Blampey, Paul-Henry Cournède and @realFlorentGinhoux We present a technology-invariant pipeline for analyses of image-based spatial-omics. Compatible with the latest technologies! biorxiv.org/content/10.110…

For all the cell therapy lovers, don't miss this conference in Paris! Gustave Roussy @ Société Française d'Immuno-Thérapie du Cancer

⏳REGISTER NOW⌛️while there's still ⏲️ for the FREE International ImmunoSchool introducing everyone that's interested to experts from around the 🌍 who will be discussing challenges & opportunities for cancer immunotherapy. Sign up here >>> eventbrite.com/e/internationa… @miriammerad

IMPROVING ADOPTIVE CELL THERAPY Deadline for abstract submission at : April 2, 2024 Please submit your abstract to the following address: [email protected]

Proud to share the results of our study on the effect of prostaglandin E2 on T cells, which was just published in Nature in which we discovered a new role for PGE2 in inhibiting interleukin-2 (IL-2) sensing and signalling in tumor-reactive T cells nature.com/articles/s4158…

Out in Cell today! We describe the first humans with inherited, complete FLT3L deficiency. Despite a lack of most dendritic cells, they reached adulthood. See the thread below for the main highlights of our paper. cell.com/cell/fulltext/…

📣 Congratulations to this year's #EHAGrants winners! We look forward to seeing them advance the field of #hematology through new collaborations and resources. Do you have a research idea in need of support? The call for #EHA Grants is now open: eha.fyi/Grants2025

Congratulations again to all our #EHAGrants winners here at #EHA2024!

🖼️ Yan Pei-Ming donne un visage à l’Institut avec un portrait monumental du professeur Gustave Roussy. Exécuté et offert par Yan Pei-Ming, peintre franco-chinois de renommée internationale, le portrait en 2,80 mètres par 2,40 mètres du Pr Gustave Roussy est accroché dans le hall

1/23 We are excited to announce that our most recent study “In vivo dendritic cell reprogramming for cancer immunotherapy” was published in Science Magazine. science.org/doi/10.1126/sc… Here is a summary of what we discovered!

Thrilled to share our first study on aging from Miriam Merad, MD, PhD lab Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute Lipschultz Precision Immunology Institute in which we demonstrate how aging promotes cancer. We show that: (1/n) science.org/doi/10.1126/sc…

3km2 repris aux russes. Notre reportage en Ukraine

Now online in Cancer Discovery: Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR-T cell Potency - by Laura Marcos-Kovandzic, Camille Bigenwald, Laurence Zitvogel, and colleagues doi.org/10.1158/2159-8… Gustave Roussy

Modifying a patient’s gut microbiome may enhance the efficacy of CAR T-cell therapy, according to research from Gustave Roussy published in the AACR journal Cancer Discovery. Learn more on the #AACRBlog: brnw.ch/21wTRa6 Camille Bigenwald

CAR T cells in the bone marrow maintain an activation state that results in inflammation that leads to hypoplasia Science Translational Medicine Camille Bigenwald 🇨🇵 science.org/doi/10.1126/sc…

Important mechanistic study on ICAHT from our French colleagues Gustave Roussy highlighting that lymphodepletion alone is insufficient to explain prolonged cytopenia after CART …a second inflammation / CAR-mediated hit within the BM is needed 👆 science.org/doi/pdf/10.112…